The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Bronchopneumonia

Bronchopneumonia

Bronchopneumonia is an inflammatory condition affecting the bronchi and alveoli of the lungs, often resulting in symptoms such as cough, fever, and difficulty breathing.
This type of pneumonia can be caused by a variety of infectious agents, including bacteria, viruses, and fungi.
Proper diagnosis and treatment are crucial to manage the condition and prevent complications.
Researchers can leverage PubCompare.ai to optimize their Bronchopneumonia studies, locating leading protocols from literature, preprints, and patents, and utilizing AI-driven comparisons to identify the best protocols and products.
This can enhance reproducibiity and accuaracy in Bronchopneumonia research, leading to more reliable and impactful findings.

Most cited protocols related to «Bronchopneumonia»

Primers and a FAM-MGB labelled Taqman probe were designed (synthesised by Applied Biosystems) and optimised to specifically amplify the HPV16 E6 region (sequence and PCR conditions listed in Table 1). Commercially available primers and a VIC-TAMRA labelled probe for the single-copy gene RNase P (TaqMan® RNase P Control Reagents, Applied Biosystems), were used as an endogenous reference in each multiplex reaction. A total reaction volume of 25 μl in each reaction contained 1× Taqman Gene Expression Master Mix (Applied Biosystems), 500 nM of each primer, 250 nM of probe, 1× RNAse P primer/probe mix and 100 ng genomic DNA. Real-time PCR reactions were performed in duplicate for all samples on an Applied Biosystems 7500 FAST system. The HPV16 positive cervical cancer cell lines, CaSki (UK Health Protection Agency Culture Collections – 87020501) and SiHa (ATCC-LGC - HTB-35) were used as positive controls and as calibrators for the assay. Normal bronchial epithelial lung cell line DNA was used as negative control in each 96 well plate.
The detection threshold for HPV positive status was set in accordance with the previously reported frequency of E6 gene copies per diploid genome for CaSki (869 copies)(22 (link)). Assuming an HPV16 driven tumour is composed of a dominant clonal population of cells, we scored as positive those samples with ≥1 E6 gene copy/diploid genome. A sample was only deemed positive if the threshold was met in both of the duplicate runs.
Publication 2011
Biological Assay Bronchopneumonia Cell Lines Cells Cervical Cancer Clone Cells Diploidy E6 protein, Human papillomavirus type 16 Gene Expression Gene Expression Regulation Genes Genome Human papillomavirus 16 Neoplasms Oligonucleotide Primers RNase P
Brains were retrieved from a total of 56 stroke survivors who came to autopsy. Six of these were demented at baseline (Fig. 1) but were included in the assessment for comparative purposes. Table 4 provides demographic details and the highest and last CAMCOG scores. In the majority of cases bronchopneumonia was recorded as the cause of death.
Macroscopic and microscopic pathology was assessed with standardized protocols as described (Kalaria et al., 2004 (link); Ihara et al., 2010 (link)). Briefly, macroscopic infarcts were detected by visual inspection while dissecting the brain, and their presence was subsequently confirmed by microscopy. Haematoxylin and eosin was used as standard stain for general neuropathological assessment of the structure of the brain, and for confirmation/detection of the infarcts. In this study, any infarct <5 mm in diameter was defined as a microinfarct. Gallyas and Bielschowsky's silver impregnation and tau immunohistochemistry were applied to assess neuritic plaques and neurofibrillary tangles for the ‘CERAD’ plaque score and ‘Braak and Braak’ neurofibrillary tangle staging. Additional staining included α-synuclein, ubiquitin and TDP-43 immunohistochemistry.
A clinical diagnosis of whether the dementia syndrome was present was made independently of neuropathological data prior to monthly clinicopathological consensus meetings where clinicians met with the pathologists to designate a final diagnosis for autopsied subjects. In all cases, additional pathologies such as Alzheimer's disease and dementia with Lewy bodies were noted. The pathological diagnosis of vascular dementia was then assigned if there was clinical evidence of dementia (DSM IV) and the presence of multiple or cystic infarcts involving cortical and subcortical structures, border-zone infarcts, lacunae, microinfarcts and small vessel disease in the general absence of a high burden of neurofibrillary pathology i.e. Braak staging et al., 2004 (link)) or obvious other primary neurodegenerative disease, and consistent with the clinical diagnostic criteria proposed by others (Chui et al., 1992 (link), 2000 (link); Roman et al., 1993 (link); Gold et al., 2002 (link)). After breakdown by diagnostic subgroups, the number of autopsies did not permit generation of sensitivity and specificity rates. Subjects were designated as mixed when there was pathological evidence of cerebrovascular disease with Alzheimer's disease-type pathology, Lewy bodies or tauopathy (frontotemporal lobar degeneration or progressive supranuclear palsy). The cases with mixed cerebrovascular disease and Alzheimer's disease had a Braak stage of V or VI and moderate to severe CERAD scores.
Publication 2011
alpha-Synuclein Alzheimer's Disease Autopsy Brain Bronchopneumonia Catabolism Cerebrovascular Accident Cerebrovascular Disorders Cortex, Cerebral Cyst Dementia, Vascular Diagnosis Eosin Frontotemporal Lobar Degeneration Gold Hematoxylin Immunohistochemistry Infarction Lewy Bodies Lewy Body Disease Microscopy Neurodegenerative Disorders Neurofibrillary Tangle Pathologic Processes Pathologists Presenile Dementia Progressive Supranuclear Palsy protein TDP-43, human Senile Plaques Staining, Silver Stains Survivors Syndrome Tauopathies Ubiquitin Vascular Diseases

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
Apnea Asthma Bronchiolitis Bronchopneumonia Child Cough Croup Cystic Fibrosis Diagnosis Ethics Committees, Research Febrile Convulsions Fever Infant, Newborn Legal Guardians Leukopenia Parent Pertussis Pharmacotherapy Pneumonia Pneumonitis Respiratory Rate Septicemia Signs and Symptoms, Respiratory Upper Respiratory Infections
Assessment of lung pathology was performed as before [15] (link), [16] (link), [17] (link). In brief, for histological examination, lungs were fixed overnight in 4% formaldehyde, embedded in paraffin and tissue sections (5 μm) after staining with H&E scored blindly for lung damage, using a cumulative score of 1 to 3 each for an extended range of parameters as recently suggested; [30] (link) i.e. congestion, intra-alveolar hemorrhage, apoptotic bodies in bronchial epithelium, necrotizing bronchiolitis, perivascular edema, bronchopneumonia, perivascular inflammation, peribronchial inflammation, vasculitis, endothelialitis, perivascular cuffs, intraluminal PMN, intraalveolar edema, mesothelial hyperplasia, fibrosis and inflammation. To avoid any sampling bias resulting from inhomogeneous distribution of SARS-CoV-2 induced lesions as frequently observed in Syrian hamsters, [30] (link) from each animal an entire lung was examined, cut in two halves along the long axis of the lung. Both halves were examined, and findings added up for final scoring. Number of hamsters per group: B.1-G (n = 11), B.1-B (n = 4), B.1.1.7 (n = 9) and B.1.351 (n = 8).
Publication 2021
Animals Apoptotic Bodies Bronchi Bronchiolitis Bronchopneumonia Edema Epistropheus Epithelium Fibrosis Formaldehyde Hamsters Hemorrhage Hyperplasia Inflammation Lung Mesocricetus auratus Mesothelium Paraffin Embedding SARS-CoV-2 SARS-CoV-2 B.1.1.7 variant SARS-CoV-2 B.1.351 variant Tissues Vasculitis

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2003
Adenoviruses, Canine Autopsy Bronchopneumonia Canis familiaris Cough Distemper Dog Diseases Leptospirosis Parvovirus, Canine Problem Behavior Respiration Disorders Respiratory Rate Rhinorrhea Serum Tissues Vaccines, Attenuated Vaccines, Inactivated Virus

Most recents protocols related to «Bronchopneumonia»

Example 5

To investigate whether a Canine/FL/04-like influenza virus had circulated among greyhound populations in Florida prior to the January 2004 outbreak, archival sera from 65 racing greyhounds were tested for the presence of antibodies to Canine/FL/04 using the HI and MN assays. There were no detectable antibodies in 33 dogs sampled from 1996 to 1999. Of 32 dogs sampled between 2000 and 2003, 9 were seropositive in both assays—1 in 2000, 2 in 2002, and 6 in 2003 (Table 5). The seropositive dogs were located at Florida tracks involved in outbreaks of respiratory disease of unknown etiology from 1999 to 2003, suggesting that a Canine/FL/04-like virus may have been the causative agent of those outbreaks. To investigate this possibility further, we examined archival tissues from greyhounds that died from hemorrhagic bronchopneumonia in March 2003. Lung homogenates inoculated into MDCK cells and chicken embryos from one dog yielded H3N8 influenza virus, termed A/Canine/Florida/242/2003 (Canine/FL/03). Sequence analysis of the complete genome of Canine/FL/03 revealed >99% identity to Canine/FL/04 (Table 4), indicating that Canine/FL/04-like viruses had infected greyhounds prior to 2004.

Patent 2024
Antibodies Biological Assay Bronchopneumonia Canis familiaris Chickens Disease Outbreaks Embryo Genome Hemorrhage Influenza Influenza A Virus, H3N8 Subtype Lung Madin Darby Canine Kidney Cells Orthomyxoviridae Population Group Respiration Disorders Respiratory Rate Sequence Analysis Serum Tissues Virus
On day 6 of the challenge, immediately prior to euthanasia, whole blood was collected in Tempus tubes, which were snap frozen, placed on dry ice and eventually stored at −80°C until analysis. Animals were euthanised by captive bolt across 3 days with group A (control group), group B (challenge group) and group C (challenge group) animals euthanised the first, second, and third day, respectively. Lungs were scored for lesions by a qualified veterinary pathologist using the AFBI scoring system (Johnston et al., 2019 (link)), which evaluates the percentage of lesions of the total lung area and on the component parts of the lung. From the lung scoring system used, the lesions were assessed and described as; acute bronchopneumonia, subacute fibrinopurulent bronchopneumonia, percentage of pneumonic tissue, interstitial oedema, abscesses, necrotic foci, haemorrhage, and others such as pleuritis and emphysema. Day 6 post-challenge was the time at which BoHV-1 infection was considered to be at its peak as previously demonstrated by Gershwin et al. (2015) (link). For this reason, blood samples collected on d 6 were chosen for downstream RNA-Seq analysis.
Publication 2023
Abscess Animals BLOOD Bronchopneumonia Dry Ice Edema Euthanasia Freezing Hemorrhage Infection Necrosis Pathologists Pleurisy Pulmonary Emphysema RNA-Seq Tissues
Pneumonia was diagnosed with chest radiography, and interpretation was accepted as written in the medical charts of patients, reporting either lobar pneumonia or bronchopneumonia, and empyema with or without pneumothorax. These reports are aligned to the WHO Standard for reporting chest radiographs in which there is presence of a dense or fluffy opacity that occupies a portion or whole of a lobe or of the entire lung, presence of fluid in the lateral pleural space between the lung and chest wall, or both.10 ,11 (link)The endpoints were number of pneumonia hospitalizations and deaths among children 3–24-month-old. The proportion of pneumonia hospitalizations was calculated before and after vaccination periods. The case-fatality rates were calculated from the deaths among the pneumonia admissions.
Publication 2023
Bronchopneumonia Child Empyema Hospitalization Lobar Pneumonia Lung Patients Pleural Cavity Pneumonia Pneumothorax Radiography, Thoracic Vaccination Wall, Chest

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Acute-Phase Reaction Anterior segment mesenchymal dysgenesis anti-IgG Antibodies B 111 Bilirubin Bronchopneumonia Compassionate Use D-Alanine Transaminase Enzymes Ethics Committees, Clinical Genotype Histamine Antagonists Hypersensitivity Legal Guardians Liver Liver Function Tests Lung Mothers olipudase alfa Patients Pharmaceutical Preparations Prunus cerasus Steroids Transaminase, Serum Glutamic-Oxaloacetic Transients Treatment Protocols
Tissue samples were fixed in formalin, processed routinely, and stained with
hematoxylin and eosin. Histologic scores and diagnoses were made by consensus
(LAJH or LS, and JLC) without knowledge of the gross diagnosis or microbiology
data. All lung sections were scored for the presence or absence of specified
histologic lesions (Supplemental Tables S4 and S5). The duration of cranioventral
and caudodorsal lung lesions was classified as acute (absence of fibrosis),
subacute (presence of immature granulation tissue), or chronic (presence of
mature fibrosis that was densely eosinophilic with fewer and smaller fibroblast
nuclei).
Histologic criteria for diagnosis of bronchopneumonia were neutrophils and
macrophages filling the lumen of alveoli and bronchioles. Histologic criteria
for alveolar and bronchiolar damage (a form of interstitial/bronchointerstitial
lung disease) were alveoli lined by hyaline membranes or type II pneumocytes and
loss of bronchiolar epithelium with attenuation of remaining epithelial cells,
respectively. Cases were diagnosed as BIP if bronchopneumonia was a predominant
histologic lesion in sections of cranioventral lung and alveolar and bronchiolar
damage were prominent in sections of caudodorsal lung. However, the lesion types
were not required to be anatomically segregated: The cranioventral lung sections
of some BIP cases had alveolar and bronchiolar damage in addition to the
bronchopneumonia required for the diagnosis of BIP, and the caudodorsal lung
sections of some BIP cases had bronchopneumonia in addition to the alveolar and
bronchiolar damage required for the diagnosis of BIP.
Publication 2023
Bronchioles Bronchopneumonia Diagnosis Eosin Eosinophilia Epithelial Cells Epithelium Fibrosis Formalin Granulation Tissue Hyalin Substance Lung Neutrophil Tissue, Membrane Tissues Tooth Socket Type-II Pneumocytes

Top products related to «Bronchopneumonia»

Sourced in United States, China, Germany, United Kingdom, Israel, Switzerland, Holy See (Vatican City State)
The BEAS-2B cell line is a human bronchial epithelial cell line derived from normal human bronchial epithelial cells. It is commonly used in cell biology research and drug discovery applications.
Sourced in United States, Germany, United Kingdom, China, Sao Tome and Principe, France, Canada, Israel, Switzerland, Japan
Collagenase I is a laboratory enzyme used for the breakdown and digestion of collagen, a major structural protein found in the extracellular matrix of various tissues. It functions as a tool for cell isolation, tissue dissociation, and tissue engineering applications.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in Japan
3-aminopropyltriethoxysilane is a silane-based coupling agent. It is used to improve the adhesion between organic and inorganic materials, such as glass, metal, and polymer surfaces.
Sourced in United States, China, United Kingdom, Germany, France, Canada, Japan, Australia, Italy, Switzerland, Belgium, New Zealand, Austria, Netherlands, Israel, Sweden, Denmark, India, Ireland, Spain, Brazil, Norway, Argentina, Macao, Poland, Holy See (Vatican City State), Mexico, Hong Kong, Portugal, Cameroon
RPMI 1640 is a common cell culture medium used for the in vitro cultivation of a variety of cells, including human and animal cells. It provides a balanced salt solution and a source of essential nutrients and growth factors to support cell growth and proliferation.
Sourced in Japan
Pentobarbital sodium is a barbiturate compound. It is commonly used as a sedative-hypnotic medication and has various laboratory applications.
Sourced in United States, United Kingdom, Germany, Japan, Canada, Sweden, France, Australia, Belgium, Italy
The cell strainer is a laboratory device used to filter and separate cells from a cell suspension. It consists of a mesh screen or filter that allows smaller particles, such as cells, to pass through while retaining larger debris or cell aggregates. The core function of the cell strainer is to provide a simple and efficient way to purify and prepare cell samples for downstream applications.
Sourced in United States
Roswell Park Memorial Institute-1640 medium is a cell culture medium developed for the growth and maintenance of various cell types. It is a complex mixture of nutrients, vitamins, amino acids, and other components that provide the necessary components for cell growth and proliferation. The medium is designed to support the in vitro cultivation of a wide range of cell lines, including those derived from human and animal sources.
Sourced in United Kingdom
The X-ChIP protocol is a standard chromatin immunoprecipitation (ChIP) procedure used to study protein-DNA interactions. It enables the isolation and identification of DNA sequences associated with specific DNA-binding proteins within the cellular chromatin.
Sourced in United States, Germany, United Kingdom
LY294002 is a small molecule that inhibits the activity of the phosphoinositide 3-kinase (PI3K) enzyme. It is commonly used in laboratory research to study the role of PI3K signaling pathways in various cellular processes.

More about "Bronchopneumonia"

Bronchopneumonia, also known as lobar pneumonia or lung inflammation, is a serious respiratory condition that affects the bronchi and alveoli of the lungs.
This type of pneumonia can be caused by a variety of infectious agents, including bacteria (such as Streptococcus pneumoniae), viruses (such as influenza), and fungi (such as Pneumocystis jirovecii).
Symptoms of bronchopneumonia may include cough, fever, difficulty breathing, and chest pain.
Proper diagnosis and treatment are crucial to manage the condition and prevent complications, such as respiratory failure, sepsis, or acute respiratory distress syndrome (ARDS).
In research settings, bronchopneumonia studies often utilize cell lines like BEAS-2B (human bronchial epithelial cells) and techniques like collagenase I digestion, FBS supplementation, and 3-aminopropyltriethoxysilane coating to create in vitro models.
Researchers may also employ RPMI 1640 medium, Pentobarbital sodium anesthesia, and cell strainers to isolate and culture relevant cell types.
To optimize bronchopneumonia research, researchers can leverage tools like PubCompare.ai to locate leading protocols from the literature, preprints, and patents, and utilize AI-driven comparisons to identify the best protocols and products.
This can enhance reproducibilty and accuaracy in bronchopneumonia research, leading to more reliable and impactful findings, such as the development of novel therapeutic approaches or improved understanding of disease pathogenesis.